SMN1 and proximal spinal muscular atrophy: In addition, CASMA detected an additional intragenic variant c.-39A>G in SMN1 in one sample (RT02) with two SMN1 copies, which was first reported in a patient with SMA (compound heterozygous with an SMN1 deletion) and may reduce normal protein expression by affecting translation [20].